Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.71 USD | -2.28% | -0.18% | -46.63% |
06:25pm | UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating | MT |
04-23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
Quotes 5-day view
Delayed Quote Nasdaq2024-04-24 | 2024-04-25 | 2024-04-26 | 2024-04-29 | 2024-04-30 | |
---|---|---|---|---|---|
Last | 16.59 $ | 16.31 $ | 16.71 $ | 17.1 $ | 16.71 $ |
Volume | 1 296 887 | 1 660 634 | 1 168 199 | 1 887 790 | 1 174 242 |
Change | -0.90% | -1.69% | +2.45% | +2.33% | -2.28% |
Opening | 16.81 | 16.50 | 16.45 | 16.90 | 16.77 |
High | 16.86 | 16.51 | 16.74 | 17.57 | 17.17 |
Low | 16.55 | 16.16 | 16.27 | 16.86 | 16.5 |
Performance
1 day | -2.28% | ||
1 week | -0.18% | ||
Current month | -9.63% | ||
1 month | -8.49% | ||
3 months | -37.72% | ||
6 months | -24.83% | ||
Current year | -46.63% | ||
1 year | -23.17% | ||
3 years | -18.73% | ||
5 years | -30.52% | ||
10 years | -16.99% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-2.28% | -0.18% | -46.63% | -23.17% | 2.82B | ||
-1.58% | -2.87% | +0.17% | +21.98% | 42.86B | ||
-1.17% | +2.24% | +10.92% | -17.31% | 42.74B | ||
-2.30% | -3.04% | +44.30% | -7.77% | 41.36B | ||
+2.89% | +5.76% | -6.20% | +17.68% | 27.68B | ||
-2.06% | -2.80% | +5.23% | +52.41% | 25.15B | ||
-2.31% | -1.45% | -24.79% | -28.69% | 18.63B | ||
-2.96% | -4.62% | +26.69% | +88.07% | 12.37B | ||
-1.34% | -4.63% | -3.13% | +20.46% | 11.92B | ||
-1.65% | -0.06% | +6.57% | +0.96% | 11.21B | ||
-2.02% | -0.75% | -18.08% | -20.22% | 10.14B | ||
+0.07% | +1.05% | -5.46% | -8.27% | 9.36B | ||
-1.29% | -1.23% | +23.31% | -16.20% | 6.68B | ||
-0.94% | +18.86% | +7.53% | -35.02% | 6.65B | ||
+0.46% | +2.81% | +29.99% | +56.31% | 6.33B | ||
-1.74% | -1.39% | -18.44% | +15.64% | 6.12B | ||
Average | -1.23% | +3.39% | +2.00% | +7.30% | ||
Weighted average by Cap. | -1.20% | +3.54% | +7.40% | +8.02% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Last transactions
Date | Price | Volume | Daily volume |
---|---|---|---|
16:00:00 | 16.71 | 247,576 | 901,728 |
15:59:59 | 16.7 | 100 | 654,152 |
15:59:59 | 16.7 | 100 | 654,052 |
15:59:59 | 16.69 | 183 | 653,952 |
15:59:59 | 16.69 | 100 | 653,769 |
15:59:59 | 16.71 | 182 | 653,669 |
15:59:59 | 16.7 | 300 | 653,487 |
15:59:59 | 16.7 | 2,409 | 653,187 |
15:59:59 | 16.7 | 491 | 650,778 |
15:59:59 | 16.7 | 100 | 650,287 |
Monthly variations
Annual change
2024 | -45.38% | ||
2023 | +96.67% | ||
2022 | -31.79% | ||
2021 | -56.34% | ||
2020 | +24.96% | ||
2019 | +164.56% | ||
2018 | -46.30% | ||
2017 | +4.40% | ||
2016 | -19.10% | ||
2015 | +12.28% | ||
2014 | +27.05% | ||
2013 | +437.42% | ||
2012 | +330.56% | ||
2011 | -10.00% | ||
2010 | -9.09% | ||
2009 | +46.67% | ||
2008 | -91.87% | ||
2007 | +25.94% | ||
2006 | -10.76% | ||
2005 | +45.49% | ||
2004 | +1.04% |
- Stock Market
- Equities
- ACAD Stock
- Quotes ACADIA Pharmaceuticals Inc.